论文部分内容阅读
目的:挖掘门诊处方中开药量为6个月量的处方,探讨其必要性及潜在风险,促进用药安全。方法:通过医院信息系统调取2015年7月1日-9月30日门诊处方中开药6个月量的处方数据,从科室、诊断、药品、患者来源地、医疗付款方式等五个方面进行整理与分析。结果:共收集符合条件的门诊处方6 986张(占同期门诊总处方的1.3%),涉及药品条目13 780条(占同期门诊总药品条目的1.2%);从科室、诊断、药品来看,主要以自身免疫性疾病患者于风湿免疫科开具免疫抑制药居多;从患者背景来看,主要以外埠和自费患者为主体人群。结论:存在门诊开药6个月量的处方与多方面因素相关;应考虑这部分患者的用药需求,规避其潜在安全风险。
OBJECTIVE: To excavate prescriptions with a prescribed quantity of 6 months in outpatient prescriptions, explore the necessity and potential risks of drug prescriptions, and promote drug safety. Methods: Through the hospital information system, we took the prescription data of 6 months from July 1, 2015 to September 30, 2015 in outpatient prescriptions. From the five aspects of department, diagnosis, medicine, the source of patients and the medical payment methods Organize and analyze. Results: A total of 6 986 eligible outpatient prescriptions were collected (accounting for 1.3% of the outpatient total prescriptions in the same period) and 13 780 drug articles (accounting for 1.2% of the total outpatient clinic drug items). In terms of departments, diagnoses and medicines, Mainly in patients with autoimmune diseases immunosuppressive drugs issued in the majority of rheumatology department; from the patient’s background, mainly outside the port and patients at their own expense for the main population. Conclusion: There are many factors related to the prescription of prescribing 6-month outpatient medication. The medication needs of these patients should be considered to avoid potential safety risks.